Illumina

Illumina is focused on improving human health by unlocking the power of the genome. Its sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe, while its microarrays provide accurate, high-throughput genotyping for a range of applications. The company’s products are facilitating breakthroughs in areas including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and more. The progress being made in genomics continues to inspire Illumina to push the boundaries of what is possible and develop the next generation of genomics solutions.